RecallDepth
Class III Terminated

Norepinephrine Bitartrate Injection, USP, 4 mg/4 mL* (1 mg/mL), 4 mL Single-dose Fliptop Vial (NDC 47335-615-40); packaged in 10 x 4 mL Single-dose Fliptop Vials per carton (NDC 47335-615-44); Rx only, Manufactured by: Gland Pharma Limited, Hyderabad-502307 India; Distributed by: Sun Phamaceutical Industries, Inc., Cranbury, NJ 08512.

This recall has been terminated (originally issued April 19, 2023).

Company
Sun Pharmaceutical Industries Inc
Recall Initiated
March 29, 2023
Posted
April 19, 2023
Recall Number
D-0529-2023
Quantity
16,450 vials
Firm Location
Princeton, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: Above the specification limits yielded for related substance norepinephrine sulfonic acid impurity during routine product monitoring.

Distribution

Nationwide in the USA

Lot / Code Info

Lot Number: G1510001, Exp 11/2023; G151002, Exp. 12/2023; and G151003, Exp 02/2024

More recalls by Sun Pharmaceutical Industries Inc

View all recalls by this company →

Other recent Class III Drug recalls